Market Segmentation
- Viral Vector Production (Research-use) Vector Type Outlook (Revenue, USD Million, 2018 - 2030)
- Adeno-associated Virus (AAV)
- Lentivirus
- Adenovirus
- Retrovirus
- Others
- Viral Vector Production (Research-use) Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cell & Gene Therapy Development
- Vaccine Development
- Biopharmaceutical & Pharmaceutical Discovery
- Biomedical Research
- Viral Vector Production (Research-use) Workflow Outlook (Revenue, USD Million, 2018 - 2030)
- Upstream Processing
- Vector Amplification & Expansion
- Vector Recovery & Harvesting
- Downstream Processing
- Purification
- Fill-finish
- Upstream Processing
- Viral Vector Production (Research-use) End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical and Biopharmaceutical Companies
- Research Institutes
- Viral Vector Production (Research-use) Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Mexico
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
